Fully in line with the implication of CXCR4 in B-cell cancers, we found cancer-relevant pathways such as Kras signaling and glycolysis as well as depletion of DNA repair pathways in CXCR4C1013G B cells (Fig. 1e). The gene discussed is KRAS; the disease is cancer.